DUBLIN, September 16, 2022 /PRNewswire/ — The “Monoclonal Antibodies for Oncology: World Markets” report has been added to from ResearchAndMarkets.com supply.
The present report supplies an in depth exposition of the worldwide Monoclonal Antibodies for Oncology Market.
This report highlights the present and future potential of the Monoclonal Antibodies for Oncology Therapy market and features a detailed evaluation of market drivers, challenges, and alternatives.
The report additionally covers market projections until 2027 and market share of main market gamers. The report particulars the Monoclonal Antibodies for Oncology market share primarily based on kind and software.
The report contains firm profiles of key gamers with detailed data on their industries, financials, product portfolios, and up to date developments. The report additionally supplies the impression of the COVID-19 pandemic on this market.
Firm profiles of key gamers together with AstraZeneca, Bristol-Myers Squibb, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co. Inc, Pfizer Inc.
The report contains
-
25 knowledge tables and 24 extra tables
-
A Transient Common Overview of the World Oncology Monoclonal Antibodies Market
-
World market pattern analyses, with market income (gross sales knowledge) for 2020 and 2021, estimates for 2022, and compound annual development fee (CAGR) projections to 2027
-
Highlights of the present and future Monoclonal Antibodies for Oncology Therapy market potential and areas of curiosity to forecast this market throughout varied segments and sub-segments
-
Evaluation of the particular market dimension of monoclonal antibodies in oncology remedy, forecast development traits and corresponding market share evaluation by antibody kind, software space and area
-
Technological evaluation of key drivers, restraints and alternatives that can form the market over the subsequent 5 years (2022 to 2027)
-
In-depth data on rising funding in R&D actions, key technological points, industry-specific challenges, main sorts of end-user markets, and implications of COVID-19 on the progress of this market
-
Evaluate of the patent panorama and new developments of the monoclonal antibodies for oncology market and associated medical trials
-
Identification of key stakeholders and evaluation of the aggressive panorama primarily based on current developments and {industry} income
Most important matters coated:
Chapter 1 Introduction
Chapter 2 Abstract and Highlights
Chapter 3 Market and Expertise Background
-
Monoclonal antibodies
-
Historical past of monoclonal antibodies
-
Benefits and drawbacks of monoclonal antibodies
-
Monoclonal antibodies in oncology
-
Sorts of monoclonal antibodies
Chapter 4 Market Dynamics
-
Market components
-
Enhance in most cancers incidence
-
New product launches
-
Enhance in well being expenditure and public funding
-
License and collaboration agreements
-
Market Obstacles
-
Value management
-
Regulatory approval pressures
-
Entry of biosimilars
-
Alternatives
-
Influence of Covid-19
Chapter 5 Market Breakdown by Kind
-
Sorts of monoclonal antibodies for oncology
-
Market overview
-
Market revenue
-
World Oncology Monoclonal Antibody Market By Kind
-
Humanized monoclonal antibodies
-
Human monoclonal antibodies
-
Chimeric monoclonal antibodies
Chapter 6 Market Cut up by Software
-
Perception
-
Lung most cancers
-
Breast most cancers
-
Colorectal most cancers
-
Leukemia
Chapter 7 Market Breakdown by Area
-
Introduction
-
North America
-
WE
-
Canada
-
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Remainder of Europe
-
Asia Pacific
-
China
-
India
-
Japan
-
Remainder of Asia Pacific
-
Remainder of the world
-
Market dimension and forecast
Chapter 8 Regulatory Elements
-
New Monoclonal Antibody Approvals for Oncology
-
Remembers, withdrawals and safety alerts
Chapter 9 Patent Examination/New Developments
Chapter 10 Aggressive Panorama
Chapter 11 Enterprise Profiles
For extra data on this report, go to https://www.researchandmarkets.com/r/9v5j5d
Media Contact:
Analysis and Markets
Laura Woodensenior
[email protected]
For EST workplace hours, name +1-917-300-0470
For USA/CAN name toll free +1-800-526-8630
For GMT workplace hours name +353-1-416-8900
US Fax: 646-607-1907
Fax (exterior the US): +353-1-481-1716
Brand: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
Present unique content material:https://www.prnewswire.com/news-releases/monoclonal-antibodies-for-oncology-global-markets-report-2022-new-product-launches-rising-healthcare-expenditures-and-government-funding–licensing -and-collaboration-agreements-301626088.html
SOURCE Analysis and Markets
